CSM
DGX icon

CAMG Solamere Management’s Quest Diagnostics DGX Stock Holding History

CAMG Solamere Management’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$1.65M Hold
11,385
– – 1.36% 25
2021
Q2 		$1.5M Hold
11,385
– – 1.3% 28
2021
Q1 		$1.46M Sell
11,385
-350
-3% -$43.1K 1.26% 30
2020
Q4 		$1.4M Hold
11,735
– – 1.17% 31
2020
Q3 		$1.34M Hold
11,735
– – 0.75% 50
2020
Q2 		$1.34M Sell
11,735
-500
-4% -$53K 0.74% 54
2020
Q1 		$982K Buy
+12,235
New +$1.27M 0.52% 74

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FMI
Fiduciary Management Inc Milwaukee, Wisconsin $8.06B AUM 6.78% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

CAMG Solamere Management's DGX Position: Q3 2021 in Review

CAMG Solamere Management held its Quest Diagnostics (DGX) position steady in Q3 2021 at 11,385 shares worth $1.65M. The position accounts for 1.36% of the portfolio, ranked #25.

CAMG Solamere Management first reported a position in DGX in Q1 2020 and has held it in 7 quarters since. 838 funds tracked by Wall St. Rank hold DGX as of Q3 2021.

  • CAMG Solamere Management held 11,385 shares of Quest Diagnostics worth $1.65M as of Q3 2021.
  • CAMG Solamere Management left its Quest Diagnostics share count unchanged in Q3 2021.
  • Quest Diagnostics made up 1.36% of CAMG Solamere Management's portfolio in Q3 2021, its #25 holding.
  • CAMG Solamere Management first reported a position in Quest Diagnostics in Q1 2020 and has held it in 7 quarters since.
  • 838 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2021.

Based on CAMG Solamere Management's 13F filing for Q3 2021, filed 12 Nov 2021.